Evidence map›Paper›PMID 42625889›Full record

ArticleClinical case reports2026

Rare Pediatric Male Presentation of Systemic Lupus Erythematosus With Catastrophic Antiphospholipid Syndrome Following Pulmonary Tuberculosis: A Case Report.

Asma Qureshi, Mahaveer Maheshwari, Aasiya Shahbaz Sakarwala, Umaya Memon, Vishan Das, Mumtaz Ali Lakho, Sandesh Kumar, Abdul Ghafoor, Siddhant Kumar Yadav

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Clinical case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Asma QureshiDepartment of Medicine Liaquat University of Medical and Health Sciences Jamshoro Pakistan.ORCID https://orcid.org/0009-0001-6972-4440
Mahaveer MaheshwariLiaquat University of Medical and Health Sciences Jamshoro Pakistan.ORCID https://orcid.org/0009-0000-8311-2064
Aasiya Shahbaz SakarwalaDow University of Health Sciences Karachi Pakistan.ORCID https://orcid.org/0009-0006-3028-1757
Umaya MemonLiaquat University of Medical and Health Sciences Jamshoro Pakistan.ORCID https://orcid.org/0009-0000-7699-5321
Vishan DasLiaquat University of Medical and Health Sciences Jamshoro Pakistan.ORCID https://orcid.org/0009-0005-5588-9892
Mumtaz Ali LakhoDepartment of Medicine Liaquat University of Medical and Health Sciences Jamshoro Pakistan.
Sandesh KumarLiaquat University of Medical and Health Sciences Jamshoro Pakistan.ORCID https://orcid.org/0009-0000-4960-9237
Abdul GhafoorLiaquat University of Medical and Health Sciences Jamshoro Pakistan.
Siddhant Kumar YadavPatan Academy of Health Sciences Lalitpur Nepal.ORCID https://orcid.org/0009-0005-4712-4574

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We report a 15-year-old with a 3-year history of polyarthritis, unexplained seizures, and pulmonary tuberculosis who presented with acute neuropsychiatric decline, fever, and thrombocytopenia. Diagnostic workup confirmed systemic lupus erythematosus with triple-positive antiphospholipid antibodies. Imaging revealed bilateral middle cerebral artery thrombosis, meeting criteria for catastrophic antiphospholipid syndrome triggered by active tuberculosis. Prompt initiation of corticosteroids, anticoagulation, and immunosuppression was critical to achieving clinical stabilization.

Indexed as

anti‐tubercular therapy (ATT)catastrophic antiphospholipid syndrome (CAPS)pulmonary tuberculosissystemic lupus erythematosus (SLE)

Identifiers

PMID42625889
PMCPMC13490713

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.